Eagle Pharmaceuticals Inc (EGRX)
0.96
+0.13
(+15.59%)
USD |
OTCM |
Nov 26, 16:00
Eagle Pharmaceuticals Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 9.951M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 8.053M |
| December 31, 2021 | 8.645M |
| September 30, 2021 | 8.271M |
| June 30, 2021 | 2.865M |
| March 31, 2021 | 1.432M |
| December 31, 2020 | 7.00M |
| September 30, 2020 | 23.00M |
| June 30, 2020 | 4.00M |
| March 31, 2020 | 0.999M |
| December 31, 2019 | 2.961M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 15.00M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 50.48M |
| September 30, 2018 | 12.11M |
| June 30, 2018 | 3.516M |
| Date | Value |
|---|---|
| March 31, 2018 | 7.003M |
| December 31, 2017 | 5.002M |
| September 30, 2017 | 13.48M |
| June 30, 2017 | 11.66M |
| March 31, 2017 | 13.65M |
| December 31, 2016 | 20.51M |
| September 30, 2016 | 16.50M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.365M |
| March 31, 2015 | -54.70M |
| December 31, 2014 | |
| September 30, 2014 | 0.0002M |
| June 30, 2014 | 0.4182M |
| March 31, 2014 | -46.49M |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2022
23.00M
Maximum
Sep 2020
5.145M
Average
2.961M
Median
Dec 2019
Stock Buybacks (Quarterly) Benchmarks
| Eli Lilly and Co | 446.10M |
| Verrica Pharmaceuticals Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -2.858M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -0.004M |